Applied DNA Sciences (NASDAQ:APDN) on Monday announced a strategic restructuring and realignment of resources to focus exclusively on its synthetic DNA manufacturing business, LineaRx. As part of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback